Utilities, Consumer...
Health Care: Drugs
Biosante Pharmaceuticals Inc. (BPAX: NASDAQ)
$0.90 0.06 | 7.06%
02/09/12 - 11:30 AM ET
6.90M / 4.97M
Vol / Avg. Vol:0.92 / 0.84
Open / Prev. Close:0.87 - 0.97
Today's Range:0.38 - 4.02
52 Wk Range:67.34%
Performance YTD:TheStreet Rating:
Portfolios with BPAX
- Portfolio NameUser Type
- UserDunDon1
- Contributor6 Drug Stocks Unworthy of B...
- Contributor3 Small-Cap Stocks on Insid...
- Contributor13 Biotech Stocks Bought an...
- UserSMITTY
- Contributor10 Most Shorted Stocks in B...
- ContributorBreakout Stocks Of The Week...
- UserMy Portfolio
- ContributorBreakout Stocks Of The Week...
- UserPFE
Latest BPAX Headlines from TheStreet
- 6 Drug Stocks Unworthy of Biotech Bull Market 02.07.12 | 12:02 pm
- Biosante Stock Falls On Unusually High Volume (BPAX) 02.07.12 | 11:02 am
- Biotech Stock Live Chat: 2012 Preview 12.15.11 | 11:12 am
- Market Preview: The Year Without a Santa Claus Rally 12.14.11 | 08:12 pm
- Novellus, BioSante: After-Hours Trading 12.14.11 | 07:12 pm
- Biosante Stock Falls On Unusually High Volume (BPAX) 12.14.11 | 04:12 pm
- BioSante Pharma Readying Release of 'Female Viagra' Study Results 12.14.11 | 12:12 pm
- The Next Big Things In Biotech: Biosante
12.02.11 | 05:12 am - 22 Hot Drugs Facing FDA Approval in 2012 11.29.11 | 08:11 am
- 3 Small-Cap Stocks on Insiders' Radar 11.18.11 | 01:11 pm
Press Releases for BPAX
- BioSante Pharmaceuticals Reports Positive LibiGel® Safety Data Review For Phase III Program - Business Wire 02.09.12 | 07:02 am
- BioSante Exchanges $5 Million Aggregate Principal Amount Of Convertible Senior Notes For 6.7 Million Shares Of Common Stock - Business Wire 02.08.12 | 11:02 am
- Investor Alert: Kahn Swick & Foti, LLC And Partner Former Louisiana Attorney General Remind Investors With Large Financial Interests Of Lead Plaintiff Deadline In Lawsuit Against BioSante Pharmaceuticals, Inc. - Business Wire 02.07.12 | 06:02 pm
- BioSante Pharmaceuticals Provides Corporate Update - Business Wire 01.31.12 | 07:01 am
- The Law Firm Of Levi & Korsinsky, LLP Launches An Investigation Into Possible Securities Laws Violations By BioSante Pharmaceuticals, Inc. - Business Wire 01.11.12 | 06:01 pm
- BioSante Pharmaceuticals Announces Results From LibiGel® Efficacy Trials - Business Wire 12.14.11 | 04:12 pm
- Ceregene Completes Enrollment Of Second Phase 2 Study Of CERE-120 For The Treatment Of Parkinson's Disease - PR Newswire 12.01.11 | 07:12 am
- BioSante Pharmaceuticals Announces Issuance Of New LibiGel® Method Of Use Patent - Business Wire 11.29.11 | 09:11 am
- BioSante Pharmaceuticals Added To NASDAQ Biotechnology Index - Business Wire 11.21.11 | 07:11 am
- BioSante Pharmaceuticals Announces Positive LibiGel® Pharmacokinetic Study Results - Business Wire 11.16.11 | 07:11 am
Partner Headlines for BPAX
- 12 Healthcare Companies Expecting Major February Catalysts - Seeking Alpha 02.01.12 | 07:02 am
- 3 Biotechs Hopefully To Get Rich Or Die Trying - Seeking Alpha 01.04.12 | 08:01 am
- Singular Research Drops Coverage on BioSante Pharma After LibGel Results - Benzinga 12.16.11 | 04:12 pm
- Singular Research Reiterates BioSante Pharmaceuticals Buy, Maintains PT - Benzinga 12.13.11 | 01:12 pm
- 7 Stocks Trading Below $6 With Heavy Insider Buying - Seeking Alpha 12.08.11 | 09:12 am
- Q3 Micro-Cap Biotech Picks By The World's Largest Fund Managers - Seeking Alpha 12.08.11 | 09:12 am
- Do These Small-Cap Insiders Know Something You Don't? - Seeking Alpha 11.20.11 | 08:11 am
- 5 Stocks Under $10: Are These Shares Undervalued? - Seeking Alpha 10.14.11 | 09:10 am
- Add Questcor To Your Diversified High-Growth Biotech Portfolio - Seeking Alpha 08.28.11 | 06:08 am
- The Two Very Best Biotechs Under $3 - Seeking Alpha 08.15.11 | 09:08 am
